Search alternatives:
significant estimates » significant time (Expand Search), significant rates (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
Showing 121 - 140 results of 21,342 for search '(( ((significant estimates) OR (significant gap)) decrease ) OR ( significant decrease decrease ))', query time: 0.60s Refine Results
  1. 121
    Table_2_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.xlsx

    Table_2_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.xlsx by Kristin R. Anderson (5478734)

    Published 2024
    Save to List
    Saved in:
  2. 122
    Image_1_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.jpg

    Image_1_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.jpg by Kristin R. Anderson (5478734)

    Published 2024
    Save to List
    Saved in:
  3. 123
    Table_1_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.pdf

    Table_1_A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors.pdf by Kristin R. Anderson (5478734)

    Published 2024
    Save to List
    Saved in:
  4. 124
    Graphs showing reproduction of selected South American annual case (a) and death (b) data using 1000 parameter sets drawn from post-burn-in distribution obtained from 4 Markov chains.

    Graphs showing reproduction of selected South American annual case (a) and death (b) data using 1000 parameter sets drawn from post-burn-in distribution obtained from 4 Markov chai... by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 125
    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected African countries.

    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected African countries. by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 126
    Diagram of SEIRV model of yellow fever transmission in humans showing zoonotic transfer from the sylvatic non-human primate reservoir (mediated by the λ<sub><i>S</i></sub> parameter) and transmission from infectious humans (mediated by the <i>R</i><sub>0</sub> parameter).

    Diagram of SEIRV model of yellow fever transmission in humans showing zoonotic transfer from the sylvatic non-human primate reservoir (mediated by the λ<sub><i>S</i></sub> paramete... by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 127
    Fig 6 -

    Fig 6 - by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 128
    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected South American countries.

    Maps of median projected λ<sub><i>S</i></sub> (a) and <i>R</i><sub>0</sub> (b) across 1st-level sub-national administrative regions in selected South American countries. by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 129
    Table of parameters.

    Table of parameters. by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 130
    Fig 7 -

    Fig 7 - by Keith Fraser (1868587)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 131
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  12. 132
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  13. 133
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  14. 134
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  15. 135
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 136
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 137
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 138
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 139
    Post-mortem lesions of chickens with decreased egg production in Yancheng in 2023.

    Post-mortem lesions of chickens with decreased egg production in Yancheng in 2023. by Yan Wang (15435)

    Published 2025
    Save to List
    Saved in:
  20. 140
    Table 6 - Gain and loss: Human and environmental wellbeing – drivers of Kilimanjaro’s decreasing biodiversity

    Table 6 - Gain and loss: Human and environmental wellbeing – drivers of Kilimanjaro’s decreasing biodiversity by Andreas Hemp (730415)

    Published 2025
    Save to List
    Saved in:

Search Tools: